Alaunos Therapeutics Inc (TCRT)

Jun 14, 2026

Alaunos Therapeutics Reports Encouraging Early Obesity Drug Results - Stocktwits

Jun 14, 2026

Jun 09, 2026

TCRT Q4 2023 Earnings: EPS Misses Estimates, No Revenue Reported, Stock DeclinesEarnings Stability Report - newsline.com

Jun 09, 2026

Jun 07, 2026

Alaunos Therapeutics (TCRT) Declines 6.56% as Stock Tests Key Support Near $2.17Swing Trade Setups - newsline.com

Jun 07, 2026

Jun 06, 2026

TCRT Q4 2023 Earnings: Wider-Than-Expected Loss on Lack of RevenueROE Trend Analysis - newsline.com

Jun 06, 2026

Jun 05, 2026

Alaunos Therapeutics (TCRT) falls on cash concerns, Nasdaq delisting risk - Bez Kabli

Jun 05, 2026

Jun 02, 2026

Alaunos Therapeutics (TCRT) Declines 4.18% as Biotech Sector Pressure Tests Key Support LevelsQuality ETF - newsline.com

Jun 02, 2026

May 31, 2026

Alaunos Therapeutics Q4 2023 Earnings: EPS Miss Widens as Pre-Revenue Biotech Faces Continued HeadwindsDebt Analysis Report - newsline.com

May 31, 2026

May 29, 2026

Alaunos Therapeutics (TCRT) Dips 6.86% as Stock Approaches Critical Support LevelChaikin Flow - The Legal Advocate

May 29, 2026

May 29, 2026

TCRT Q4 2023 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Advances PipelineEarnings Season Outlook - newsline.com

May 29, 2026

May 27, 2026

Alaunos Therapeutics (TCRT) CEO takes 3,700 shares instead of salary - Stock Titan

May 27, 2026

May 27, 2026

Alaunos reports positive preclinical obesity drug results across weight, liver, insulin markers - MSN

May 27, 2026

May 27, 2026

Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Weis Holger - Moomoo

May 27, 2026

May 26, 2026

Alaunos Therapeutics (TCRT) Drops 2.69% as Support Level Holds SteadyDip Buy Trade - The Legal Advocate

May 26, 2026

May 26, 2026

Alaunos Reports Positive Preclinical Metabolic Data for ALN1003 - TipRanks

May 26, 2026

May 26, 2026

Alaunos reports preclinical data for obesity drug candidate ALN1003 - Investing.com UK

May 26, 2026

May 26, 2026

Alaunos reports preclinical data for obesity drug candidate ALN1003 By Investing.com - Investing.com South Africa

May 26, 2026

May 26, 2026

Alaunos Therapeutics Reports Positive Preclinical Results for ALN1003 in Addressing Metabolic Disease Markers - Quiver Quantitative

May 26, 2026

May 26, 2026

ALN1003 obesity data and cash runway update from Alaunos (NASDAQ: TCRT) - Stock Titan

May 26, 2026

May 23, 2026

TCRT Q4 2023 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports No RevenueGuidance Update - Newser

May 23, 2026

May 21, 2026

Alaunos Therapeutics (TCRT) Q4 2023 Earnings Fall Short: EPS $-4.90 Misses MarkBuyback Announcement Report - Newser

May 21, 2026

May 19, 2026

Alaunos Therapeutics Announces Promising Preclinical Results for ALN1003 in Metabolic Syndrome and Obesity Models - Minichart

May 19, 2026

May 18, 2026

Alaunos Therapeutics (TCRT) Reveals Promising Preclinical Data f - GuruFocus

May 18, 2026

May 18, 2026

Alaunos Therapeutics, Inc.Common Stock (Nasdaq:TCRT) Stock Quote - FinancialContent

May 18, 2026

May 18, 2026

Alaunos reports preclinical data for obesity drug candidate - Investing.com UK

May 18, 2026

May 18, 2026

Alaunos reports preclinical data for obesity drug candidate By Investing.com - Investing.com Nigeria

May 18, 2026

May 18, 2026

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models - The Manila Times

May 18, 2026

May 18, 2026

Alaunos (Nasdaq: TCRT) shows ALN1003 obesity data, reports $0.354M cash - Stock Titan

May 18, 2026

May 18, 2026

Experimental obesity pill shows liver and insulin-resistance effects in mice - Stock Titan

May 18, 2026

May 17, 2026

TCRT Alaunos Therapeutics reports widening losses as revenue plummets 50 shares fall 326Social Buy Zones - newser.com

May 17, 2026

May 15, 2026

Ziopharm: Q1 Earnings Snapshot - marketscreener.com

May 15, 2026

May 15, 2026

Alaunos Therapeutics, Inc. 1Q 2026: Revenue $0K, EPS $(0.59) — 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

Alaunos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

May 15, 2026

Alaunos Therapeutics (NASDAQ: TCRT) Q1 2026 loss, cash runway and Nasdaq equity deficiency - Stock Titan

May 15, 2026

May 14, 2026

Headline News about Alaunos Therapeutics, Inc.Common Stock - FinancialContent

May 14, 2026

May 11, 2026

MSN Money - MSN

May 11, 2026

May 10, 2026

TCRT Alaunos Therapeutics reports widening losses as revenue plummets 50%, shares fall 3.26%.Value Pick - newser.com

May 10, 2026

May 08, 2026

Alaunos Therapeutics (TCRT) Eps Diluted (TTM) - Zacks Investment Research

May 08, 2026

May 08, 2026

TCRT Stock Price, Quote & Chart | ALAUNOS THERAPEUTICS INC (NASDAQ:TCRT) - ChartMill

May 08, 2026